These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis. Yacoub L; Goldman H; Odze RD Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315 [TBL] [Abstract][Full Text] [Related]
5. The expression of 8-hydroxydeoxyguanosine in oesophageal tissues and tumours. Räsänen JV; Sihvo EI; Ahotupa MO; Färkkilä MA; Salo JA Eur J Surg Oncol; 2007 Dec; 33(10):1164-8. PubMed ID: 17467227 [TBL] [Abstract][Full Text] [Related]
6. The relationship of endocrine cells, dysplasia and carcinoembryonic antigen in Barrett's mucosa to adenocarcinoma of the oesophagus. Griffin M; Sweeney EC Histopathology; 1987 Jan; 11(1):53-62. PubMed ID: 2881873 [TBL] [Abstract][Full Text] [Related]
7. GATA6 expression in Barrett's oesophagus and oesophageal adenocarcinoma. Pavlov K; Honing J; Meijer C; Boersma-van Ek W; Peters FT; van den Berg A; Karrenbeld A; Plukker JT; Kruyt FA; Kleibeuker JH Dig Liver Dis; 2015 Jan; 47(1):73-80. PubMed ID: 25445407 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of metaplastic non-goblet columnar lined oesophagus shows phenotypic similarities to Barrett's oesophagus: a study in an Asian population. Srivastava S; Liew MS; McKeon F; Xian W; Yeoh KG; Ho KY; Teh M Dig Liver Dis; 2014 Feb; 46(2):170-5. PubMed ID: 24290871 [TBL] [Abstract][Full Text] [Related]
9. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis. Jankowski J; Hopwood D; Pringle R; Wormsley KG Am J Gastroenterol; 1993 Mar; 88(3):402-8. PubMed ID: 8438848 [TBL] [Abstract][Full Text] [Related]
10. Reduced expression of αGlcNAc in Barrett's oesophagus adjacent to Barrett's adenocarcinoma--a possible biomarker to predict the malignant potential of Barrett's oesophagus. Iwaya Y; Hasebe O; Koide N; Kitahara K; Suga T; Shinji A; Muraki T; Yokosawa S; Yamada S; Arakura N; Tanaka E; Nakayama J Histopathology; 2014 Mar; 64(4):536-46. PubMed ID: 24117499 [TBL] [Abstract][Full Text] [Related]
11. Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma. Morita S; Matsumoto Y; Okuyama S; Ono K; Kitamura Y; Tomori A; Oyama T; Amano Y; Kinoshita Y; Chiba T; Marusawa H Carcinogenesis; 2011 Nov; 32(11):1706-12. PubMed ID: 21890457 [TBL] [Abstract][Full Text] [Related]
12. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma. Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma. Lord RV; Frommer DJ; Inder S; Tran D; Ward RL Aust N Z J Surg; 2000 Jan; 70(1):26-33. PubMed ID: 10696939 [TBL] [Abstract][Full Text] [Related]
14. Proliferating cell nuclear antigen in the assessment of Barrett's mucosa. Gillen P; McDermott M; Grehan D; Hourihane DO; Hennessy TP Br J Surg; 1994 Dec; 81(12):1766-8. PubMed ID: 7827934 [TBL] [Abstract][Full Text] [Related]